Published November 11, 2025
| Version v1
Other
Open
What is the evidence on the cost-effectiveness of Fractional Exhaled Nitric Oxide (FeNO) testing in asthma diagnosis and management?
Description
The clinical bottom line is that FeNO testing appears cost-effective for adult asthma management, reducing exacerbations and medication usage, but its cost-effectiveness in children remains uncertain, highlighting an area for further research.
Files
21d5cfd2-e5e8-42c5-aee2-551801522823.pdf
Files
(18.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:e712b56613b56f96c2d924c4d5884977
|
18.5 kB | Preview Download |